• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人遗传性出血性毛细血管扩张症的医学管理。

Medical management of haemorrhagic hereditary telangiectasia in adult patients.

机构信息

Unidad de Telangiectasia Hemorrágica Hereditaria, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de LLobregat, Barcelona, España; Servicio de Medicina Interna, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de LLobregat, Barcelona, España; Facultad de Medicina y Ciencias de la Salud, Universitat de Barcelona, Barcelona, España.

Unidad de Telangiectasia Hemorrágica Hereditaria, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de LLobregat, Barcelona, España; Servicio de Neumología, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de LLobregat, Barcelona, España.

出版信息

Med Clin (Barc). 2019 Apr 5;152(7):274-280. doi: 10.1016/j.medcli.2018.09.015. Epub 2018 Nov 27.

DOI:10.1016/j.medcli.2018.09.015
PMID:30502301
Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant inherited Rare Disease that causes a systemic anomalous vascular overgrowth. The approach and follow-up of these patients should be from multidisciplinary units. Its diagnosis is carried out according to Curaçao clinical Criteria. Telangiectasia in the nasal mucosa cause recurrent epistaxis, the main symptom of HHT and difficult to control. The three types of hepatic shunting, hepatic artery to hepatic vein, hepatic artery to portal vein or to portal vein to hepatic vein, can cause high-output heart failure, portal hypertension or porto-systemic encephalopathy, respectively. These types of vascular involvement can be established using computerised tomography. Pulmonary arteriovenous fistula should be screened for all HHT patients by contrast echocardiography. The main objective is to review the management of epistaxis, liver and lung involvement of the adult patient with HHT.

摘要

遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传的罕见疾病,会导致全身异常血管过度生长。这些患者的治疗和随访应该由多学科团队进行。其诊断依据是 Curaçao 临床标准。鼻腔黏膜的毛细血管扩张导致反复鼻出血,这是 HHT 的主要症状,且难以控制。三种类型的肝分流,肝动脉至肝静脉、肝动脉至门静脉或门静脉至肝静脉,分别可导致高输出量心力衰竭、门静脉高压或门体脑病。这些类型的血管受累可以通过计算机断层扫描来确定。所有 HHT 患者都应通过对比超声心动图筛查肺动静脉瘘。主要目的是回顾 HHT 成年患者的鼻出血、肝脏和肺部受累的管理。

相似文献

1
Medical management of haemorrhagic hereditary telangiectasia in adult patients.成人遗传性出血性毛细血管扩张症的医学管理。
Med Clin (Barc). 2019 Apr 5;152(7):274-280. doi: 10.1016/j.medcli.2018.09.015. Epub 2018 Nov 27.
2
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中的肝血管畸形
Semin Liver Dis. 2008 Aug;28(3):247-58. doi: 10.1055/s-0028-1085093. Epub 2008 Sep 23.
3
Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report.一名60岁肯尼亚黑人女性的明确遗传性出血性毛细血管扩张症:病例报告
J Med Case Rep. 2016 May 25;10(1):126. doi: 10.1186/s13256-016-0909-4.
4
Pulmonary hypertension and hepatic encephalopathy: lethal complications of Rendu-Osler-Weber disease.肺动脉高压与肝性脑病:遗传性出血性毛细血管扩张症的致命并发症。
J R Coll Physicians Edinb. 2014;44(2):126-9. doi: 10.4997/JRCPE.2014.207.
5
Osler-Rendu-Weber with liver involvement.伴有肝脏受累的奥斯勒-伦杜-韦伯病。
J Belge Radiol. 1998 Aug;81(4):184-5.
6
Hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Dec;65(12):614-8.
7
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings.遗传性出血性毛细血管扩张症中的肝血管畸形:影像学表现
AJR Am J Roentgenol. 1994 Nov;163(5):1105-10. doi: 10.2214/ajr.163.5.7976883.
8
Severe pulmonary hypertension associated with hepatic arteriovenous malformation in a patient with hereditary haemorrhagic telangiectasia.一名患有遗传性出血性毛细血管扩张症的患者出现与肝动静脉畸形相关的严重肺动脉高压。
BMJ Case Rep. 2018 Sep 18;2018:bcr-2018-226067. doi: 10.1136/bcr-2018-226067.
9
[Liver involvement in hereditary hemorrhagic telangiectasia].[遗传性出血性毛细血管扩张症中的肝脏受累]
Acta Gastroenterol Latinoam. 2011 Sep;41(3):225-9.
10
A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)的临床管理和药物治疗综述。
Curr Vasc Pharmacol. 2010 Jul;8(4):473-81. doi: 10.2174/157016110791330771.

引用本文的文献

1
Minimal encephalopathy in hereditary hemorrhagic telangiectasia patients with portosystemic vascular malformations.患有门体静脉血管畸形的遗传性出血性毛细血管扩张症患者的轻微脑病
Orphanet J Rare Dis. 2024 Dec 21;19(1):484. doi: 10.1186/s13023-024-03493-3.
2
Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.生长抑素类似物在遗传性出血性毛细血管扩张症慢性胃肠道出血中的长期应用。
Front Med (Lausanne). 2023 May 12;10:1146080. doi: 10.3389/fmed.2023.1146080. eCollection 2023.
3
Pulmonary arteriovenous malformation and inherent complications with solitary lung nodule biopsy-literature overview and case report.
肺动静脉畸形及孤立性肺结节活检的固有并发症——文献综述与病例报告
Radiol Case Rep. 2022 May 6;17(7):2353-2361. doi: 10.1016/j.radcr.2022.04.003. eCollection 2022 Jul.
4
Rethinking growth factors: the case of BMP9 during vessel maturation.重新审视生长因子:血管成熟过程中骨形态发生蛋白9的实例
Vasc Biol. 2022 Feb 7;4(1):R1-R14. doi: 10.1530/VB-21-0019. eCollection 2022 Feb 1.
5
Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry.西班牙目前的 HHT 遗传概述及其表型相关性:RiHHTa 注册中心的数据。
Orphanet J Rare Dis. 2020 Jun 5;15(1):138. doi: 10.1186/s13023-020-01422-8.
6
Gender differences in hereditary hemorrhagic telangiectasia severity.遗传性出血性毛细血管扩张症严重程度的性别差异。
Orphanet J Rare Dis. 2020 Mar 2;15(1):63. doi: 10.1186/s13023-020-1337-5.
7
Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings.遗传性出血性毛细血管扩张症患者的胃肠道出血:危险因素及内镜检查结果
J Clin Med. 2019 Dec 28;9(1):82. doi: 10.3390/jcm9010082.
8
PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.1 型遗传性出血性毛细血管扩张症患者的 PI3K(磷脂酰肌醇 3-激酶)激活与血管内皮细胞增殖。
Cells. 2019 Aug 24;8(9):971. doi: 10.3390/cells8090971.
9
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.静脉血栓栓塞和遗传性出血性毛细血管扩张症患者的自然史。RIETE 登记处的研究结果。
Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8.